Dr. Cole has served on the journal editorial board from 1994-2001 as the Editor of "Trophoblast Disease Update". He has written more than 100 articles on hCG structure, physiology and immunoassay and on clinical applications of hCG or hCG-related molecules. He has a 1.17 FWCI in the Medicine category of SciVal where he has published throughout the various disciplines and maintains an average of 12.6 citations per article from 2009-2014. He has experience with international, single, and institutional collaboration. Awards and recognition for Dr. Cole include the Institute for Anticancer Research, Biannual Prize for best research; American Association for Clinical Chemistry, Most Outstanding Research Contributor to Clinical Chemistry Prize; Gynecology Oncology, Outstanding Speaker Award; and International Society for Study of Trophoblastic Disease, Gold Medal for most outstanding research.Dr. Butler attained his PhD from the University of London and after a Post-Doctoral Fellowship at Yale University School of Medicine he became an Assistant Professor at the University of New Mexico with the USA hCG Reference Service. Steve returned to the UK and, following positions at Queen Mary University of London and London Metropolitan University he spent seven years at Middlesex University as Reader (Associate Professor) in Biomedical Diagnostics. Dr Butler has been a Director for medical diagnostics companies and and is now a consultant biomedical diagnostics expert with a particular interest in diagnostics and therapeutics relating to hCG in pregnancy and cancer. He has published over 80 peer reviewed scientific articles, reviews, letters, patents, abstracts and book chapters in the field of molecular diagnostics. He is a global opinion leader on the structure and function of human chorionic gonadotropin (hCG) and its role as a diagnostic marker in fertility, pregnancy and cancer.